SOA Wealth Advisors’s VanEck Pharmaceutical ETF PPH Stock Holding History

SOA Wealth Advisors’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-35	Closed	-$3.16K	–	921
2025 Q1	$3.16K	Hold	35	–	–	﹤0.01%	672
2024 Q4	$2.99K	Buy	35 +1	+3%	+$90	﹤0.01%	655
2024 Q3	$3.27K	Hold	34	–	–	﹤0.01%	638
2024 Q2	$3.13K	Hold	34	–	–	﹤0.01%	643
2024 Q1	$3.09K	Hold	34	–	–	﹤0.01%	661
2023 Q4	$2.76K	Hold	34	–	–	﹤0.01%	662
2023 Q3	$2.7K	Hold	34	–	–	﹤0.01%	682
2023 Q2	$2.65K	Buy	34 +1	+3%	+$78	﹤0.01%	692
2023 Q1	$2.59K	Hold	33	–	–	﹤0.01%	699
2022 Q4	$2.58K	Hold	33	–	–	﹤0.01%	707
2022 Q3	$2K	Buy	33 +1	+3%	+$74	﹤0.01%	720
2022 Q2	$2K	Hold	32	–	–	﹤0.01%	710
2022 Q1	$2K	Hold	32	–	–	﹤0.01%	816
2021 Q4	$2K	Hold	32	–	–	﹤0.01%	787
2021 Q3	$2K	Hold	32	–	–	﹤0.01%	796
2021 Q2	$2K	Sell	32 -78	-71%	-$5.56K	﹤0.01%	780
2021 Q1	$7K	Hold	110	–	–	﹤0.01%	582
2020 Q4	$7K	Buy	+110	New	+$7.05K	﹤0.01%	567

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

SOA Wealth Advisors's PPH Position: Q2 2025 in Review

SOA Wealth Advisors sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2025, closing a stake of 35 shares — an estimated $3.16K sold.

SOA Wealth Advisors first reported a position in PPH in Q4 2020 and held it in 18 quarters. The position peaked at $7K in Q1 2021. 129 funds tracked by Wall St. Rank hold PPH as of Q2 2025.

SOA Wealth Advisors reported no remaining VanEck Pharmaceutical ETF position as of Q2 2025 after selling out during the quarter.
SOA Wealth Advisors sold 35 VanEck Pharmaceutical ETF shares in Q2 2025, an estimated $3.16K.
SOA Wealth Advisors first reported a position in VanEck Pharmaceutical ETF in Q4 2020 and held it in 18 quarters.
SOA Wealth Advisors's VanEck Pharmaceutical ETF position peaked at $7K in Q1 2021.
129 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2025.

Based on SOA Wealth Advisors's 13F filing for Q2 2025, filed 18 Jul 2025.